117 related articles for article (PubMed ID: 25255602)
1. Diabetic neuropathy: Part 2.
Gupta A; Gupta Y
J Pak Med Assoc; 2014 Jul; 64(7):846-50. PubMed ID: 25255602
[TBL] [Abstract][Full Text] [Related]
2. [Progress in therapy for and diagnosis of diabetic neuropathies].
Baba M
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):779-86. PubMed ID: 19472531
[No Abstract] [Full Text] [Related]
3. [Examination of questionnaires regarding diabetic peripheral neuropathy in epalrestat-treated patients and their usefulness in the treatment of the patients during the treatment course].
Ito A; Ishii-Nozawa R; Ibuki C; Atarashi H; Kataoka H; Takeuchi K
Yakugaku Zasshi; 2009 Oct; 129(10):1239-47. PubMed ID: 19797880
[TBL] [Abstract][Full Text] [Related]
4. [Prevention and treatment of diabetic neuropathy].
Uesaka Y
Nihon Rinsho; 2002 Oct; 60 Suppl 10():256-9. PubMed ID: 12430238
[No Abstract] [Full Text] [Related]
5. Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine.
Kawai T; Takei I; Tokui M; Funae O; Miyamoto K; Tabata M; Hirata T; Saruta T; Shimada A; Itoh H
J Diabetes Complications; 2010; 24(6):424-32. PubMed ID: 19716319
[TBL] [Abstract][Full Text] [Related]
6. [Nerve flow dynamics in the pathogenesis of diabetic neuropathy].
Ueda H
Nihon Rinsho; 2005 Jun; 63 Suppl 6():499-503. PubMed ID: 15999759
[No Abstract] [Full Text] [Related]
7. Effect of aldose reductase inhibitor on cutaneous nerve fiber length in diabetic patients.
Yasuda H; Hirai A; Joko M; Terada M; Kawabata T; Maeda K; Haneda M; Kashiwagi A; Maeda T; Kikkawa R
Diabetes Care; 2000 May; 23(5):705. PubMed ID: 10834436
[No Abstract] [Full Text] [Related]
8. [Development of therapeutic agents for diabetic neuropathies].
Nakamura J
Nihon Rinsho; 2005 Jun; 63 Suppl 6():614-21. PubMed ID: 15999780
[No Abstract] [Full Text] [Related]
9. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy.
Ramirez MA; Borja NL
Pharmacotherapy; 2008 May; 28(5):646-55. PubMed ID: 18447661
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.
Ando H; Takamura T; Nagai Y; Kaneko S;
J Diabetes Complications; 2006; 20(6):367-70. PubMed ID: 17070440
[TBL] [Abstract][Full Text] [Related]
11. [Effects of the aldose reductase inhibitor on diabetic polyneuropathy--the efficacy of F wave measurement].
Shimada H; Miki T; Kyogoku I; Kawagishi T; Inaba M; Okuno Y; Nishizawa Y; Morii H
No To Shinkei; 1998 Sep; 50(9):817-20. PubMed ID: 9789304
[TBL] [Abstract][Full Text] [Related]
12. [Diabetic complication].
Iwamoto Y
Nihon Rinsho; 1991 Sep; 49(9):2136-40. PubMed ID: 1960879
[No Abstract] [Full Text] [Related]
13. [Epalrestat].
Hotta N
Nihon Rinsho; 1997 Nov; 55 Suppl():204-11. PubMed ID: 9434468
[No Abstract] [Full Text] [Related]
14. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.
Schemmel KE; Padiyara RS; D'Souza JJ
J Diabetes Complications; 2010; 24(5):354-60. PubMed ID: 19748287
[TBL] [Abstract][Full Text] [Related]
15. [Recent advances in treatment of diabetic polyneuropathy].
Baba M
Nihon Rinsho; 2012 Jul; 70 Suppl 5():451-7. PubMed ID: 23156437
[No Abstract] [Full Text] [Related]
16. [Drug therapy of symptoms in peripheral diabetic neuropathy. Tricyclic antidepressive agents and other drugs].
Sindrup SH
Ugeskr Laeger; 1990 Feb; 152(8):554-6. PubMed ID: 2309368
[No Abstract] [Full Text] [Related]
17. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
Shindo H; Tawata M; Aida K; Onaya T
J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of painful diabetic polyneuropathy].
Haanpää M
Duodecim; 2014; 130(12):1235-42. PubMed ID: 25016669
[TBL] [Abstract][Full Text] [Related]
19. Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients.
Baba M; Kimura K; Suda T; Yagihashi S;
J Peripher Nerv Syst; 2006 Jun; 11(2):176-8. PubMed ID: 16787519
[No Abstract] [Full Text] [Related]
20. Diabetic peripheral neuropathy: current perspective and future directions.
Singh R; Kishore L; Kaur N
Pharmacol Res; 2014 Feb; 80():21-35. PubMed ID: 24373831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
